MENLO PARK, Calif.--(BUSINESS WIRE)--Sea Lane Biotechnologies, LLC (Sea Lane) today announced the first demonstration of a new class of biotherapeutic molecules called Surrobodies™ with the potential to impart transformative new abilities and benefits into next generation biologic treatments.
